NRAS and melanoma: Previous studies reported that the number of mutations in genes involved in the MAPK pathway, including BRAF and NRAS, was increased from premalignant lesions to melanoma; it was therefore stated that MAPK becomes activated at the earliest stage of neoplasia and progressively ramps up as malignant transformation proceeds [13, 26].